Form 8-K - Current report:
SEC Accession No. 0001104659-11-020426
Filing Date
2011-04-15
Accepted
2011-04-15 17:14:08
Documents
6
Period of Report
2011-04-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a11-10394_18k.htm 8-K 39375
2 EX-5.1 a11-10394_1ex5d1.htm EX-5.1 13021
3 EX-10.1 a11-10394_1ex10d1.htm EX-10.1 171479
4 EX-99.1 a11-10394_1ex99d1.htm EX-99.1 14031
5 GRAPHIC g103941kgi001.jpg GRAPHIC 2445
6 GRAPHIC g103941mmi001.jpg GRAPHIC 4551
  Complete submission text file 0001104659-11-020426.txt   248804
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 11763655
SIC: 2834 Pharmaceutical Preparations